Striate+ lands in its next major market, Singapore, priming the company for further launches in the ASEAN region.

Orthocell (ASX: OCC) has received regulatory approval from Singapore’s Health Sciences Authority to commence regional sales ...

Brazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.

Regulatory nod expands global footprint for bone regeneration product, boosting revenue. Orthocell Limited (ASX: OCC) has secured regulatory approval from Singapore’s Health Sciences Authority (HSA) ...

The S&P/ASX 200 closed 6.3 points higher, up 0.08%. Coal stocks popped on a well received half-year results release from New ...

The visual system is the part of the central nervous system that is required for visual perception – receiving, processing and interpreting visual information to build a representation of the ...